Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRG2 | P18507 | 6/20 | 0.40 |
| ▸ | GABRB3 | P28472 | 6/20 | 0.40 |
| ▸ | GABRA1 | P14867 | 5/20 | 0.40 |
| ▸ | GABRA5 | P31644 | 4/20 | 0.40 |
| ▸ | GABRA3 | P34903 | 4/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.35 |
| ▸ | GABRA2 | P47869 | 4/20 | 0.34 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.34 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.34 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19697968 | 0.95 | GABRG2 (0.40) | GABRG2GABRB3GABRA1GABRA5GABRA3 | |
| SCHEMBL19697920 | 0.92 | GABRA1 (0.38) | GABRG2GABRB3GABRA1GABRA5GABRA3 | |
| SCHEMBL19697915 | 0.90 | ESR2 (0.42) | KDM4EATML3MBTL1NR3C1ALDH1A1 | |
| SCHEMBL21022651 | 0.89 | ALDH1A1 (0.43) | GABRG2GABRB3GABRA1GABRA5GABRA3 | |
| SCHEMBL17949631 | 0.89 | GABRG2 (0.41) | GABRG2GABRB3GABRA1GABRA5GABRA3 | |
| SCHEMBL18347486 | 0.88 | GABRG2 (0.45) | GABRG2GABRB3GABRA1GABRA5GABRA3 | |
| SCHEMBL18347485 | 0.88 | GABRG2 (0.43) | GABRG2GABRB3GABRA1GABRA5GABRA3 | |
| SCHEMBL17949625 | 0.88 | GABRG2 (0.44) | GABRG2GABRB3GABRA1GABRA5GABRA3 | |
| SCHEMBL19697785 | 0.88 | NR3C1 (0.38) | KDM4EATML3MBTL1NR3C1ALDH1A1 | |
| SCHEMBL19697986 | 0.87 | GABRA1 (0.38) | GABRG2GABRB3GABRA1GABRA5GABRA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230309390-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG ELECTRONICS CO LTD (KR) | 2023-09-28 | — | — | US | disclosed |
| US-20230301179-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-09-21 | — | — | US | disclosed |
| US-20230174560-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-06-08 | — | — | US | disclosed |
| US-20230165130-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-05-25 | — | — | US | disclosed |
| US-20230069900-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-03-09 | — | — | US | disclosed |
| US-11552258-B2 | Organic light-emitting device comprising emission layer satisfying specific singlet excitation energy level conditions | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-01-10 | — | — | US | disclosed |
| US-11539012-B2 | Organic light-emitting device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2022-12-27 | — | — | US | disclosed |
| US-20220149287-A1 | ORGANIC LIGHT-EMITTING DEVICE | Research & Business Foundation Sungkyunkwan University (KR) | 2022-05-12 | — | — | US | disclosed |
| US-20220115600-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2022-04-14 | — | — | US | disclosed |
| US-20220093878-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2022-03-24 | — | — | US | disclosed |
| US-20210284906-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2021-09-16 | — | — | US | disclosed |
| US-20210167311-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2021-06-03 | — | — | US | disclosed |
| US-20200321537-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-10-08 | — | — | US | disclosed |
| US-20170358755-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-12-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230165130-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | CYP1A1, CYP2E1, AOX1 | GABRG2 3130/4885GABRB3 3600/4885GABRA1 2004/4885 |
| US-20230174560-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | CRY1, AOX1, CYP1A1 | GABRG2 2639/4885GABRB3 3356/4885GABRA1 1634/4885 |
| US-11552258-B2 | Organic light-emitting device comprising emission layer satisfying specific singlet excitation energy level conditions | EML4, NES, TBL2 | GABRG2 3369/4885GABRB3 3421/4885GABRA1 3818/4885 |
| US-20220115600-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING ORGANIC LIGHT-EMITTING DEVICE | CYP1A1, AOX1, CYP2E1 | GABRG2 3387/4885GABRB3 3832/4885GABRA1 2066/4885 |
| US-20230309390-A1 | ORGANIC LIGHT-EMITTING DEVICE | L1CAM, EML4, OR10J3 | GABRG2 2495/4885GABRB3 2099/4885GABRA1 2457/4885 |
| US-20230301179-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | CRY1, AOX1, CYP1A1 | GABRG2 2728/4885GABRB3 3525/4885GABRA1 1689/4885 |
| US-20170358755-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | ARL1, CCNL2, CRY1 | GABRG2 3947/4885GABRB3 4270/4885GABRA1 3191/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.